The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(5-(cyclopropylcarbamoyl)-2-methylphenyl)-1-methyl-1H-indole-6-carboxamide ID: ALA2402003
PubChem CID: 58328191
Max Phase: Preclinical
Molecular Formula: C21H21N3O2
Molecular Weight: 347.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2ccn(C)c2c1
Standard InChI: InChI=1S/C21H21N3O2/c1-13-3-4-15(20(25)22-17-7-8-17)11-18(13)23-21(26)16-6-5-14-9-10-24(2)19(14)12-16/h3-6,9-12,17H,7-8H2,1-2H3,(H,22,25)(H,23,26)
Standard InChI Key: PUZHKYXTJMQSQI-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
16.3737 -6.1091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6573 -5.6993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9446 -6.1111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6555 -4.8732 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3700 -4.4586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0834 -4.8730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7974 -4.4591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7960 -3.6320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0747 -3.2206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3636 -3.6370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6452 -3.2289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5136 -4.8709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5150 -5.6970 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.2283 -4.4566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9445 -4.8684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3558 -5.5797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7675 -4.8636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2335 -5.6992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5213 -6.1104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9484 -6.9322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2391 -7.3456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5211 -6.9393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9127 -7.4966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2548 -8.2475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0745 -8.1541 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6326 -8.7632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
2 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
10 11 1 0
7 12 1 0
12 13 2 0
12 14 1 0
14 15 1 0
16 15 1 0
17 16 1 0
15 17 1 0
3 18 2 0
18 19 1 0
19 22 2 0
21 20 2 0
20 3 1 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 21 1 0
25 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 347.42Molecular Weight (Monoisotopic): 347.1634AlogP: 3.63#Rotatable Bonds: 4Polar Surface Area: 63.13Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.44CX LogD: 3.44Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -1.55
References 1. Wrobleski ST, Lin S, Dhar TG, Dyckman AJ, Li T, Pitt S, Zhang R, Fan Y, Doweyko AM, Tokarski JS, Kish KF, Kiefer SE, Sack JS, Newitt JA, Witmer MR, McKinnon M, Barrish JC, Dodd JH, Schieven GL, Leftheris K.. (2013) The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode., 23 (14): [PMID:23746475 ] [10.1016/j.bmcl.2013.05.047 ]